跳至主要内容
临床试验/DRKS00033194
DRKS00033194招募中Unknown

Skeletal muscle phenotype and its association with glucometabolic status in patients with type 2 diabetes, overweight-to-obese and healthy individuals. - MuscleDiab

Deutsches Luft- und Raumfahrtzentrum, Institut für Luft- und Raumfahrtmedizin0 个研究点目标入组 60 人开始时间: 2023年12月7日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
24 Years 至 69 Years(—)
性别
All

入选标准

  • Individuals with T2D:
  • Female and male individuals with T2D diagnosis according to ADA criteria
  • No participation in structured exercise programs for =6 months
  • BMI between 19 and 35 kg/m2
  • Age between 24 and 69 years
  • Signed informed consent
  • Overweight-toobese individuals:
  • Female and male participants with
  • normal glucose tolerance
  • Sex-, age- and physical activity levelmatched to individuals with T2
  • No participation in structuredexercise programs for =6 months
  • BMI between 25 to 40 kg/m2
  • Signed informed consent
  • Normal-weight individuals:
  • Metabolically healthy female and male participants with normal glucose tolerance
  • Sex-, age- and physical activity levelmatched to individuals with T2D
  • No participation in structured exercise programs for =6 months
  • BMI between 19 to 24.9 kg/m2
  • Signed informed consent

排除标准

  • Contra-indications against biopsy (e.g. impaired hemostasis,
  • keloidosis, history of adverse reactions to local anesthesia or to surgical
  • procedures)
  • Contra-indications against magnetic resonance imaging, including metal implants or other osteosynthesis material, not MRI compatible stents, clips
  • etc., pacemakers, infusion pumps, claustrophobia
  • neurological conditions
  • including strokes, brain hemorrhage, aneurysms, brain tumors,
  • neurodegenerative diseases, seizures, head trauma based on medical history
  • Cardiovascular conditions including acute coronary artery disease with coronary angina or myocardial infarction in the last 6 months,
  • heart failure (NYHA III-IV), ventricular or atrial arrhythmias, pacemaker, recurrent syncope,
  • Autonomic disorders
  • Chronic pulmonary diseases (COPD, severe asthma, pulmonary fibrosis)
  • Sleep apnea, insomnia or narcolepsy based on medical history
  • Any other medical condition that the investigators consider contraindication to the study procedures that would make it unsafe or
  • confound the measurements, e.g. medication with insulin, sulfonylurea, glinide,medication influencing hemostasis (e.g. ASS, anticoagulants)

研究者

发起方
Deutsches Luft- und Raumfahrtzentrum, Institut für Luft- und Raumfahrtmedizin

相似试验

Skeletal muscle phenotype and its association with... | 临床试验